Lupin Limited (BOM:500257)
India · Delayed Price · Currency is INR 1,931.40
-8.65 (-0.45%)
At close: Oct 24, 2025
Lupin Employees
Lupin had 24,006 employees as of March 31, 2025. The number of employees increased by 2,138 or 9.78% compared to the previous year.
Employees
24,006
Change (1Y)
2,138
Growth (1Y)
9.78%
Revenue / Employee
9.74M INR
Profits / Employee
1.54M INR
Market Cap
882.18B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 24,006 | 2,138 | 9.78% |
| Mar 31, 2024 | 21,868 | 935 | 4.47% |
| Mar 31, 2023 | 20,933 | 1,144 | 5.78% |
| Mar 31, 2022 | 19,789 | 1,216 | 6.55% |
| Mar 31, 2021 | 18,573 | 271 | 1.48% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Tata Consultancy Services | 607,979 |
| Reliance Industries | 403,303 |
| Infosys | 323,578 |
| State Bank of India | 236,226 |
| HDFC Bank | 214,521 |
| ICICI Bank | 182,665 |
| Life Insurance Corporation of India | 91,606 |
| Bajaj Finance | 64,092 |
Lupin News
- 2 days ago - Lupin launches Authorized Generic Version of Ravicti Oral Liquid in the U.S. - Business Upturn
- 16 days ago - Lupin launches strategic partnership program to expand reach of PrecisionSphere long-acting injectable platform - Business Upturn
- 17 days ago - Lupin shares rally over 3% after announcing $250 million investment in new manufacturing plant - Business Upturn
- 24 days ago - Lupin launches Rivaroxaban for Oral Suspension in the US - Business Upturn
- 25 days ago - Lupin shares jump over 3% after receiving U.S. FDA approval for Rivaroxaban for Oral Suspension - Business Upturn
- 25 days ago - Lupin secures U.S. FDA approval for Rivaroxaban for Oral Suspension - Business Upturn
- 27 days ago - Lupin subsidiary Nanomi B.V. to acquire VISUfarma B.V. for €190 million - Business Upturn
- 4 weeks ago - Lupin shares edge higher after tentative US FDA approval for HIV drug generic - Business Upturn